Therapeutic Asset Ratings

753 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
9-valent human papillomavirus recombinant vaccine AIN2	Shanghai Bovax Biotechnology Co., Ltd.	P3	B (60)
9-valent human papillomavirus recombinant vaccine AIN3	Shanghai Bovax Biotechnology Co., Ltd.	P3	B (60)
9-valent human papillomavirus recombinant vaccine Genital Wart	Xiamen University	P3	B (60)
9-valent human papillomavirus recombinant vaccine Penile Cancer	Shanghai Bovax Biotechnology Co., Ltd.	P3	B (60)
9-valent human papillomavirus recombinant vaccine Penile/Perineal /Perianal Intraepithelial Neoplasia	Xiamen University	P3	B (60)
9-valent human papillomavirus recombinant vaccine PIN-1	Shanghai Bovax Biotechnology Co., Ltd.	P3	B (60)
9-valent human papillomavirus recombinant vaccine PIN3	Shanghai Bovax Biotechnology Co., Ltd.	P3	B (60)
Moderna Bivalent Mrna Vaccine COVID-19 Vaccines	Monash University	P3	B (60)
Moderna Bivalent Mrna Vaccine HIV	Monash University	P3	B (60)
Moderna Bivalent Mrna Vaccine Organ Transplantation	Monash University	P3	B (60)
PCV 13 Multiple Sclerosis, Relapsing-Remitting	Novartis Pharmaceuticals	P3	B (60)
Pfizer Bivalent Covid-19 Vaccine COVID-19 Vaccines	Monash University	P3	B (60)
Pfizer Bivalent Covid-19 Vaccine HIV	Monash University	P3	B (60)
Pfizer Bivalent Covid-19 Vaccine Organ Transplantation	Monash University	P3	B (60)
Supemtek® Morbid Obesity	Assistance Publique - Hôpitaux de Paris	P3	B (60)
Tetanus Toxoid Multiple Sclerosis, Relapsing-Remitting	Celgene	P3	B (60)
Tetanus Toxoid Relapsing Multiple Sclerosis	Celgene	P3	B (60)
Tetanus Toxoid, Reduced Diphtheria Toxoid And Acellular Pertussis Vaccine Multiple Sclerosis, Relapsing-Remitting	Celgene	P3	B (60)
Vaxigriptetra® Morbid Obesity	Assistance Publique - Hôpitaux de Paris	P3	B (60)
cd105/yb-1/sox2/cdh3/mdm2-polyepitope plasmid dna vaccine HER2 Negative Breast Carcinoma	University of Washington	P2	B (60)
GVAX Pancreatic Cancer	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	B (60)
Modified Vaccinia Virus Ankara Vaccine Expressing P53 Recurrent Ovarian Epithelial Cancer	City of Hope Medical Center	P2	B (60)
Modified Vaccinia Virus Ankara Vaccine Expressing P53 Recurrent Platinum-Resistant Primary Peritoneal Carcinoma	City of Hope Medical Center	P2	B (60)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine Advanced Ovarian Carcinosarcoma	Mayo Clinic	P2	B (60)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine Advanced Ovarian Clear Cell Adenocarcinoma	Mayo Clinic	P2	B (60)

Showing 51 to 75 of 753 assets

PreviousPage 3 of 31Next